SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " jac " 7,092 found 🔀 AI-powered Shuffle
How Brad Pitt appears in “Jackass: Best and Last”: 'It was wild,' says Steve-O
The "Inglourious Basterds" actor shows up in the latest "Jackass" movie via archival footage from 2001.
Boniakowski: Electrical supply business buys Princeton commercial buildings for $1.9 million
An electrical supply company has acquired two adjacent buildings in Princeton for a combined $1.9 million, in a set of deals arranged by The Boniakowski Commercial Real Estate Group.
Clippers draft pick Narcisse Ngoy announces he will play at Auburn next year in unique draft-and-stash situation
World Cup 2026: USMNT stunned by Türkiye in stoppage time, losing perfect group stage run
Tempo's Marina Mabrey ties WNBA records with 53 points and 9 3-pointers in rout of Sparks
Mabrey joins A'ja Wilson and Liz Cambage in the record books.
USA vs. Türkiye score, live updates: USMNT finishes group play before knockout match with Bosnia and Herzegovina
World Cup 2026: Christian Pulisic won't start for USMNT's group stage finale against Türkiye
This Is Probably Your Last Chance to Buy a Cheap MacBook for a While
Apple has dramatically jacked up the price of MacBooks, making the current Prime Day pricing that much more enticing.
How the LaMelo Ball era in Charlotte came to its sudden end
MLB All-Star 2026: Shohei Ohtani and Ernie Clement receive automatic spots after winning Phase 1 of fan vote
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
The Politics Hour: The big winners in MD's primary elections
Leading Democratic nominee for Montgomery County Executive Will Jawando talks about his message to voters, dark money, and data centers. Plus, Tara Jackson wins the Democratic nomination for Prince George's County State's Attorney and WAMU's Alex Koma on D.C. lawmakers greenlighting the budget.
Blue Jackets acquire Valeri Nichushkin from Avalanche: Sources
Nichushkin, 31, has four years left on his current deal and a 12-team no-trade list.
Entrepreneurs pitched business ideas to Yahoo Finance
Yahoo Finance Executive Editor Brian Sozzi is on the hunt for the next big business breakthrough. Check out the absolute best pitches and standout moments from the innovators making waves at Cannes Lions.
Rays' Craig Kimbrel allows 1-out, 9th-inning homer to spoil combined no-hitter against Royals
HOMETOWN ENTERTAINMENT: FloydFest 2026 Daydream
Organizers say FloydFest will feature Tedeschi Trucks Band, My Morning Jacket, Stephen Wilson Jr. and Lukas Nelson.
This Week in Jacksonville: Business Edition - Tim Cost reflects on 14 years leading Jacksonville University
As Jacksonville University prepares to welcome new leadership, outgoing President Tim Cost says his focus remains on the institution’s future rather than his own legacy.
Renewed Dansby Swanson makes Cubs history with 15 RBI across 3 games vs. Mets, including 11 in doubleheader
Athletics' Jacob Wilson: Out of Athletics' lineup
Athletics' Jacob Wilson: Out of Athletics' lineup
LaMelo Ball trade grades: The Hornets' logic makes sense, but what is Minnesota's thought process?
Their Family Business Went From Bankruptcy to a $4 Billion Snack Empire: Inside Jack Link’s Wild Entrepreneurial Ride
Meat, risk, and NASCAR — here's how Jack Link's CEO Troy Link has grown his family business into a global phenomenon.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
NFL offseason power rankings: No. 30 Arizona Cardinals restart the road to relevance, yet again
Mets commit six infield errors in embarrassing loss to Cubs: 'This team is in the depths of despair'
Shohei Ohtani calls his own pitches vs. Twins after apparent dispute with catcher Dalton Rushing
Mookie Betts continues resurgent streak with 300th career homer in Dodgers win
NBA Draft Round 2 winners and losers: LaMelo Ball on the move? Must the Celtics trade Jaylen Brown? And players were drafted as well?
Jaguars roster: Where does DeeJay Dallas fit in backfield?
DeeJay Dallas enters training camp looking to carve out a role in the Jaguars' crowded backfield, with special teams likely playing a key part.
NBA Draft: Knicks continue spate of trades, deal No. 31 and 55 picks to Rockets after moving out of first round
Jacob Elordi, Teyana Taylor invited to join Oscars voters
Jacob Elordi, Julia Garner, Simu Liu, Jenna Ortega and Teyana Taylor are among the boldface names invited to join the Academy of Motion Picture Arts and Sciences.
Kennedy scion Jack Schlossberg loses crowded New York City congressional primary
Kennedy family scion and political novice Jack Schlossberg lost Tuesday to New York state Assembly Member Micah Lasher, in a closely watched and crowded Democratic primary for an open congressional seat in the heart of Manhattan.
Switzerland vs Canada Extended Highlights
Check out the full game highlights between Switzerland and Canada in the 2026 FIFA World Cup™. Announced by Jacqui Oatley and Warren Barton.
Switzerland vs Canada Highlights
Check out the full game highlights between Switzerland and Canada in the 2026 FIFA World Cup™. Announced by Jacqui Oatley and Warren Barton.
5 players who might be playing themselves out of a trade, from Freddy Peralta to Willy Adames
Alex Rodriguez on how to build a business empire and what an MLB strike would mean to baseball
Baseball star Alex Rodriguez started building his business with a single $250,000 investment in 1995.
A-Rod talks his journey through the 'two B's': Baseball & Business
Former MLB All-Star and A-Rod Corp CEO Alex Rodriguez sits down with Yahoo Finance Executive Editor Brian Sozzi at the 2026 Cannes Lions International Festival of Creativity to discuss his upbringing and personal journeys through baseball and his ventures off the field in the world of business.
Virginia Business Spotlights Tysons Office Managing Partner Jack L. White
Virginia Business magazine featured Jack L. White, managing partner of McGuireWoods’ Tysons, Virginia, office, in its June 2026 edition. The profile is part of the magazine’s “Virginia 500” series spotlighting...
World Cup Group B live updates, scores: Follow Bosnia and Herzegovina vs. Qatar, Canada vs. Switzerland
Film academy invites 529 new members, including Jenna Ortega, the Safdie brothers and Jacob Elordi
The Academy of Motion Picture Arts and Sciences on Wednesday invited 529 members to the Oscar voting body, a new class that brings the group’s membership to nearly double what it was a decade ago.
We’ve Been Wrong About Sunlight for Decades—Here’s What the Science Says
We've been demonizing sunlight for years. A new book by Rowan Jacobsen digs into the science—and says we've got it all wrong.
Elon Musk identified as buyer of Jacksonville business in FTC filing
Trillionaire Elon Musk bought the assets of Jacksonville-based APR Energy, according to a Federal Trade Commission filing.
'Voicemails for Isabelle' is Netflix's latest big hit — but viewers should expect tears
Zoey Deutch's Netflix rom-com has pleased both audiences and critics alike. But what viewers weren't expecting was how many tissues they would need while watching.
NFL offseason power rankings: No. 31 New York Jets try to put Aaron Glenn's horrific first season behind them
Lamar Jackson: Former Bears OC Declan Doyle is 'mind-blowing'
Former Chicago Bears and current Baltimore Ravens OC Declan Doyle is drawing high praise from QB Lamar Jackson.
Men’s Health: Caring for the Body, Mind and Spirit
FORT POLK, La. — Seeking help is often viewed as a vulnerability in military culture, but healthcare providers at Bayne-Jones Army Community Hospital are reframing it as a tactical strength. In observance of Men's Health Month, a BJACH family physician, a mental health provider and the hospital chaplain have partnered to deliver a unified message: peak military readiness requires actively maintaining the body, mind and spirit. From utilizing routine screenings to leveraging physical discipline to build mental resilience and cultivating a strong spiritual community, the team outlines actionable steps to overcome the physical, emotional and isolation barriers that uniquely impact men.
How wearable tech aims to innovate women's health care
Clair Health co-founder and CTO (Chief Technology Officer) Abhinav Agarwal comes on Asking for a Trend to explain how the company is using AI models in its hormone monitoring device and how new doctors, specifically OBGYNs, can use it to learn more.
From consulting to an in-house role
Julian Jackson joined Amer Sports in September 2024, making the leap from the world of consulting to an in-house role.
Mamdani extends influence with clean sweep in N.Y., Trump hedges in South Carolina: The latest primary results
Your complete guide to the most important contests between now and November.
NBA Draft first round reaction: Winners! Losers! Surprises! Steals!
Program gives Jacksonville teens hands-on training with science and public safety pros
For a group of local high school students, summer break has become an opportunity to step into the shoes of scientists, engineers, firefighters, police officers
SF Supervisor Jackie Fielder to return after mental health leave; reflects on recovery in video post
San Francisco Supervisor Jackie Fielder will return to City Hall next week after taking a three-month leave of absence, saying she stepped away from the job because her mental health demanded it. "This leave, and even my whole adult life, has been an entire journey on mental health," Fielder said. "And I know I'm not the only one who struggles with it."
NBA Draft 2026: Champion Knicks trade out of first round via swaps with Lakers, Mavericks and Suns
NBA Draft 2026: Defending champion Knicks trade back with Lakers, who pick Cameron Carr at No. 24
NBA Draft: Spurs beef up with shot-blocking Kentucky F Jayden Quaintance, UConn C Tarris Reed Jr. to play with Victor Wembanyama
2026 NBA Draft grades, first-round pick-by-pick analysis: Wizards get A+ for selecting AJ Dybantsa No. 1
Race, politics fueled airport takeover effort, Jackson Mayor Horhn testifies
Jackson Mayor John Horhn was the second witness called in Day 2 of Jackson's airport takeover trial.
United Airlines debuted cheaper Polaris business class fares
United Airlines just made some lie-flat business class seats cheaper on long-haul flights, but there's a catch. What to know about the new Polaris base fares before buying.
Michigan names Mike Boynton Jr. interim head coach after Dusty May leaves for Mavericks job
2026 NBA Draft order, news, live updates: Wizards pick No. 1 overall with AJ Dybantsa, Darryn Peterson among top prospects
SF supervisor Fielder to return to City Hall after mental health leave
(BCN) — San Francisco Supervisor Jackie Fielder will resume her duties next week after taking a three-month leave of absence due to mental health. “I’m coming clear-eyed and groun…
World Cup 2026: Record-breaking Cristiano Ronaldo leads Portugal's 5-0 rout of Uzbekistan
Trail Blazers hiring T-Wolves assistant Micah Nori as head coach, reportedly on 1-year deal with team options for subsequent seasons
TIME Launches The CEO Moment with Sam Jacobs, Expanding Its Coverage of Business Leadership with a New Video Interview Series
TIME launched The CEO Moment with Sam Jacobs, a new monthly video interview series hosted by TIME's Editor in Chief that expands TIME's coverage of business leadership through in-depth conversations with the executives shaping today's business landscape.
How Jaguars have differentiated themselves under Gladstone and Coen
Mathieu Araujo's latest comments offered insight into the organizational alignment and culture the Jaguars have worked to establish under Liam Coen.
Zendaya and Tom Holland kept their wedding quiet. Their 'Spider-Man' red carpet style is anything but.
Some of these looks shouldn't work on paper — but this is Zendaya.
Will the Columbus Blue Jackets Draft Oscar Hemming?
The Columbus Blue Jackets have the 14th overall pick in the 2026 NHL Draft. There are debates about whether or […]
Fantasy Baseball: Recapping every offensive position ahead of the midpoint of the 2026 season
NFL offseason power rankings: No. 32 Miami Dolphins start over in Year Zero, but at least with Malik Willis aboard
Caitlin Clark, DeWanna Bonner altercation leads to six technical fouls, frustration from Clark: 'It's ridiculous'
Herring Named College Sports Communicators Academic All-America® Third Team
AUSTIN, Texas – East Carolina senior outfielder Jack Herring garnered his first All-American honors for the 2026 season, being named to the College Sports Co...
Who are the new 'Love Island USA' bombshells? 6 stars dumped in major Casa Amor twist.
This year's Casa Amor challenge brought a record number of bombshells to the villa — and a dramatic elimination that sent six hopefuls home.
Sporticast: Why Netflix, EA Have Their Own World Cup Games
On the 563rd Sporticast episode, hosts Jacob Feldman and Justin Birnbaum discuss some of the biggest sports business stories of the week, including a detailed breakdown of Netflix’s FIFA World Cup video game. Following Electronic Arts and FIFA’s split in 2022, both parties now have World Cup-related offerings on the market. Electronic Arts recently launched …
Giannis Antetokounmpo trade grades: Miami doesn't flinch at cost of acquiring a top-5 player
Jordan vs Algeria Highlights
Check out the full game highlights between Jordan and Algeria in the 2026 FIFA World Cup™. Announced by Jacqui Oatley and Warren Barton.
Timberwolves reportedly trading Julius Randle to Nets in salary dump, agree with Ayo Dosunmu on $112M deal
S.F. supervisor Jackie Fielder to return to City Hall after mental health leave
The Mission District supervisor Jackie Fielder is back to San Francisco City Hall after a doctor-recommended three-month rest.
What’s at Stake on a Blockbuster NYC Election Day
Tuesday is make or break for everyone from Jack Schlossberg to Brad Lander and will serve as a major test of Zohran Mamdani’s clout.
Men's College World Series: West Virginia far ahead in Rocco's Jello Shot Challenge, but Oklahoma in second, UNC third as finals conclude
Oklahoma won the Men's College World Series. But West Virginia won the Jello Shot Challenge.
Giannis Antetokounmpo reportedly traded to Heat in blockbuster deal that spells the end of an era for Bucks
Timberwolves reportedly trading Julius Randle to Nets in salary dump, signing Ayo Dosunmu to $112M deal
NBA Draft 2026: Full draft order, list of picks, where to watch, odds, Giannis Antetokounmpo trade rumors and more
Lamar Jackson ranked No. 2 among fantasy QBs for 2026
Lamar Jackson landed behind Josh Allen and ahead of Jalen Hurts in a 2026 fantasy football quarterback ranking.
7-in-Seven Top High School Sports Moments: Iowa football state title
The Yellow Jackets won the program's first state championship after outlasting the North DeSoto Griffins 50-43 back in December.